Cite
HARVARD Citation
Nordström, T. et al. (2021). Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. Lancet oncology. 22 (9), pp. 1240-1249. [Online].